Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neurofibrosarcoma × metarrestin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Neurofibrosarcoma 1 Colorectal Neoplasms 1

Interventions

selinexor 2 pembrolizumab 1 pazopanib 1 metarrestin 1 fludarabine phosphate 1 fludarabine 1 decitabine and cedazuridine drug combination 1 Proton Therapy 1 Mesna 1 Liquid Biopsy 1 Ifosfamide 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04222413 2026-03-13

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting

GastrointestinalSarcoma

Pancreatic Neoplasms, Colorectal Neoplasms, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡